Background: High salt intake is a well-known risk factor for osteoporosis, but the association between bone mass and urinary sodium excretion has not been studied as yet. This study investigates the hypothesis that urinary sodium excretion is negatively associated with bone mass and the risk of osteoporosis. Methods: This cross-sectional study was performed using data from the Korea National Health and Nutrition Examination Survey, 2008-2011. Participants (n = 16,279) were divided into age groups; men were categorized as younger than 50 years of age or 50 years or greater, women were categorized as pre- or post-menopausal. Results: Multivariate linear regression analysis showed that urinary sodium excretion was negatively associated with bone mineral content (BMC) and bone mineral density (BMD) in premenopausal and postmenopausal women. Sodium excretion was negatively associated with BMC and BMD of the lumbar spine in women with normal bone health, osteopenia and osteoporosis, but there was no association in men. Increased sodium excretion was significantly associated with risk for osteoporosis/osteopenia in premenopausal women. Conclusions: This study demonstrates that urinary sodium excretion is negatively associated with bone health, suggesting that high salt intake could be a possible risk factor for osteoporosis in Korean women, but not in men.

Keywords:
Bone mass, Korean, Osteoporosis, Urinary sodium excretion, Menopause
1.
Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N, et al: Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 1999;10:259-264.
2.
Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention: Korea Health Statistics: Korean National Health and Nutrition Examination Survey 2008-2011. Seoul, Korea Centers for Disease Control and Prevention, 2014.
3.
Shortt C, Flynn A: Sodium-calcium inter-relationships with specific reference to osteoporosis. Nutr Res Rev 1990;3:101-115.
4.
Breslau NA, McGuire JL, Zerwekh JE, Pak CY: The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 1982;55:369-373.
5.
Evans CE, Chughtai AY, Blumsohn A, Giles M, Eastell R: The effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women. Eur J Clin Nutr 1997;51:394-399.
6.
Lin PH, Ginty F, Appel LJ, Aickin M, Bohannon A, Garnero P, Barclay D, Svetkey LP: The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults. J Nutr 2003;133:3130-3136.
7.
Greendale GA, Barrett-Connor E, Edelstein S, Ingles S, Haile R: Dietary sodium and bone mineral density: results of a 16-year follow-up study. J Am Geriatr Soc 1994;42:1050-1055.
8.
Ilich JZ, Brownbill RA, Coster DC: Higher habitual sodium intake is not detrimental for bones in older women with adequate calcium intake. Eur J Appl Physiol 2010;109:745-755.
9.
Devine A, Criddle RA, Dick IM, Kerr DA, Prince RL: A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr 1995;62:740-745.
10.
Park SM, Joung JY, Cho YY, Sohn SY, Hur KY, Kim JH, Kim SW, Chung JH, Lee MK, Min YK: Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass. Eur J Clin Nutr 2015;69:361-366.
11.
Teucher B, Dainty JR, Spinks CA, Majsak-Newman G, Berry DJ, Hoogewerff JA, Foxall RJ, Jakobsen J, Cashman KD, Flynn A, Fairweather-Tait SJ: Sodium and bone health: impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women. J Bone Miner Res 2008;23:1477-1485.
12.
Rural Resource Development Institute: Food Composition Table, ed 7. Suwon, Rural Resource Development Institute, 2006.
13.
Kim SW, Jeon JH, Choi YK, Lee WK, Hwang IR, Kim JG, Lee IK, Park KG: Association of urinary sodium/creatinine ratio with bone mineral density in postmenopausal women: KNHANES 2008-2011. Endocrine 2015;49:791-799.
14.
Bedford JL, Barr SI: Higher urinary sodium, a proxy for intake, is associated with increased calcium excretion and lower hip bone density in healthy young women with lower calcium intakes. Nutrients 2011;3:951-961.
15.
The Korean Nutrition Society: Ministry of Health and Welfare; Korean Food and Drug Administration. Dietary Reference Intakes for Korean. The Korean Nutrition Society, 2010.
16.
Centers for Disease Control and Prevention (CDC): Sodium intake among adults - United States, 2005-2006. MMWR Morb Mortal Wkly Rep 2010;59:746-749.
17.
Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, Engell RE, Lim SS, Danaei G, Mozaffarian D; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE): Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 2013;3:e003733.
18.
Kim J, Lim SY, Kim JH: Nutrient intake risk factors of osteoporosis in postmenopausal women. Asia Pac J Clin Nutr 2008;17:270-275.
19.
Castenmiller JJ, Mensink RP, van der Heijden L, Kouwenhoven T, Hautvast JG, de Leeuw PW, Schaafsma G: The effect of dietary sodium on urinary calcium and potassium excretion in normotensive men with different calcium intakes. Am J Clin Nutr 1985;41:52-60.
20.
Goulding A: Fasting urinary sodium/creatinine in relation to calcium/creatinine and hydroxyproline/creatinine in a general population of women. N Z Med J 1981;93:294-297.
21.
Itoh R, Suyama Y: Sodium excretion in relation to calcium and hydroxyproline excretion in a healthy Japanese population. Am J Clin Nutr 1996;63:735-740.
22.
Jones G, Beard T, Parameswaran V, Greenaway T, von Witt R: A population-based study of the relationship between salt intake, bone resorption and bone mass. Eur J Clin Nutr 1997;51:561-565.
23.
Evans CE, Chughtai AY, Blumsohn A, Giles M, Eastell R: The effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women. Eur J Clin Nutr 1997;51:394-399.
24.
Lietz G, Avenell A, Robins SP: Short-term effects of dietary sodium intake on bone metabolism in postmenopausal women measured using urinary deoxypyridinoline excretion. Br J Nutr 1997;78:73-82.
25.
Ginty F, Flynn A, Cashman KD: The effect of dietary sodium intake on biochemical markers of bone metabolism in young women. Br J Nutr 1998;79:343-350.
26.
Natri AM, Kärkkäinen MU, Ruusunen M, Puolanne E, Lamberg-Allardt C: A 7-week reduction in salt intake does not contribute to markers of bone metabolism in young healthy subjects. Eur J Clin Nutr 2005;59:311-317.
27.
Shortt C, Flynn A: Sodium-calcium inter-relationships with specific reference to osteoporosis. Nutr Res Rev 1990;3:101-115.
28.
Sellmeyer DE, Schloetter M, Sebastian A: Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab 2002;87:2008-2012.
29.
Breslau NA, McGuire JL, Zerwekh JE, Pak CY: The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 1982;55:369-373.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.